Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial

Nav

General Info

Geography

Germany (DEU)

Time period covered

01/2004 - 12/2006

Data type

Scientific literature

Keywords

Atrial fibrillation and flutter

Citation

Authors

Schmieder RE, Kjeldsen SE, Julius S, McInnes GT, Zanchetti A, Hua TA, VALUE Trial Group

Journal

J Hypertens

Volume

Issue

Pages

403–11

Publication year

2008

Suggested citation

Schmieder RE, Kjeldsen SE, Julius S, McInnes GT, Zanchetti A, Hua TA, VALUE Trial Group. Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial. J Hypertens. 2008; 26(3): 403–11.

GHDx Entry last modified on: Oct 8, 2022

Header sites

Search form

Main menu

Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial

Nav